(via NewsDirect)
Revenue for the year to
A noteworthy development was a successful fundraising event that raised £9.9 million, enhancing the firm's cash position and enabling further product development.
In partnership with Corteva Agriscience, Eden introduced Ecovelex, a new seed treatment product designed to repel birds from maize, marking a new category for the company. This product received temporary approval in
Additionally, Eden expanded its product range to include an insecticide targeting pests like mites and aphids, which has undergone extensive field testing with over 140 trials worldwide.
Regulatory approvals for Mevalone were a significant focus, with expansions in the US including crucial approval in
Looking forward, Smith said the company is optimistic about 2024, despite potential challenges from climate conditions and regulatory dependencies. Key future developments include ongoing product label expansions and regulatory authorisations, particularly in
Contact Details
+44 20 7989 0813
uk@proactiveinvestors.com
Copyright (c) 2024 TheNewswire - All rights reserved.
Copyright (c) 2024 TheNewswire - All rights reserved., source